• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.血管内皮生长因子G+405C多态性可能会增加患乳头状甲状腺癌的风险。
J Clin Lab Anal. 2017 Nov;31(6). doi: 10.1002/jcla.22110. Epub 2016 Dec 7.
2
VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population.意大利人群中血管内皮生长因子(VEGF)基因多态性与结直肠癌易感性
Int J Colorectal Dis. 2009 Feb;24(2):165-70. doi: 10.1007/s00384-008-0586-x. Epub 2008 Oct 2.
3
Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.上游转录因子1(USF1)单核苷酸多态性与甲状腺乳头状癌易感性的关联。
Clin Endocrinol (Oxf). 2016 Apr;84(4):564-70. doi: 10.1111/cen.12832. Epub 2015 Aug 14.
4
Vascular endothelial growth factor polymorphisms increase the risk of developing Graves' disease.血管内皮生长因子多态性增加 Graves 病发病风险。
Int Immunopharmacol. 2012 Oct;14(2):133-7. doi: 10.1016/j.intimp.2012.06.018. Epub 2012 Jul 5.
5
Single nucleotide polymorphisms of ataxia telangiectasia mutated and the risk of papillary thyroid carcinoma.共济失调毛细血管扩张突变基因单核苷酸多态性与甲状腺乳头状癌风险的关系。
Environ Mol Mutagen. 2015 Jan;56(1):70-6. doi: 10.1002/em.21898. Epub 2014 Sep 4.
6
Role of MDM2 309T>G (rs2279744) and I/D (rs3730485) polymorphisms and haplotypes in risk of papillary thyroid carcinoma, tumor stage, tumor size, and early onset of tumor: A case control study.MDM2 309T>G(rs2279744) 和 I/D(rs3730485) 多态性及单倍型与甲状腺乳头状癌风险、肿瘤分期、肿瘤大小及发病年龄的关系:病例对照研究。
J Cell Physiol. 2019 Aug;234(8):12934-12940. doi: 10.1002/jcp.27960. Epub 2018 Dec 13.
7
Four common vascular endothelial growth factor polymorphisms (-2578C>A, -460C>T, +936C>T, and +405G>C) in susceptibility to lung cancer: a meta-analysis.四种常见血管内皮生长因子基因多态性(-2578C>A、-460C>T、+936C>T和+405G>C)与肺癌易感性的Meta分析
PLoS One. 2013 Oct 1;8(10):e75123. doi: 10.1371/journal.pone.0075123. eCollection 2013.
8
Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.X射线修复交叉互补基因3(XRCC3)基因多态性与中国汉族人群甲状腺乳头状癌易感性的关联
Tumour Biol. 2016 Jan;37(1):979-87. doi: 10.1007/s13277-015-3882-4. Epub 2015 Aug 12.
9
Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.白细胞介素-10 - 1082基因多态性与甲状腺乳头状癌相关。
Mol Biol Rep. 2014 May;41(5):3091-7. doi: 10.1007/s11033-014-3169-7. Epub 2014 Jan 28.
10
Functional evaluation of TERT-CLPTM1L genetic variants associated with susceptibility of papillary thyroid carcinoma.与甲状腺乳头状癌易感性相关的TERT-CLPTM1L基因变异的功能评估
Sci Rep. 2016 May 17;6:26037. doi: 10.1038/srep26037.

引用本文的文献

1
Genetic interaction analysis of VEGF-A rs3025039 and VEGFR-2 rs2071559 identifies a genetic profile at higher risk to develop nodular goiter.VEGF-A rs3025039 和 VEGFR-2 rs2071559 的遗传交互作用分析确定了发生结节性甲状腺肿的更高风险遗传特征。
J Endocrinol Invest. 2020 Feb;43(2):149-155. doi: 10.1007/s40618-019-01092-9. Epub 2019 Aug 2.
2
Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation.甲状腺癌诊断和代谢调控的代谢组学进展。
Endocrine. 2019 Jul;65(1):1-14. doi: 10.1007/s12020-019-01904-1. Epub 2019 Apr 1.
3
Metabolic Reprogramming in Thyroid Carcinoma.甲状腺癌中的代谢重编程
Front Oncol. 2018 Mar 23;8:82. doi: 10.3389/fonc.2018.00082. eCollection 2018.
4
Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk.血管内皮生长因子基因多态性与肾细胞癌风险的关联
Technol Cancer Res Treat. 2017 Dec;16(6):978-986. doi: 10.1177/1533034617712396. Epub 2017 Jun 8.

本文引用的文献

1
Which is the best predictor of thyroid cancer: thyrotropin, thyroglobulin or their ratio?甲状腺癌的最佳预测指标是什么:促甲状腺激素、甲状腺球蛋白还是它们的比值?
Hormones (Athens). 2016 Apr;15(2):256-263. doi: 10.14310/horm.2002.1677.
2
Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer.术前血清促甲状腺激素水平与甲状腺癌的定量评估
Oncotarget. 2016 Jun 7;7(23):34918-29. doi: 10.18632/oncotarget.9201.
3
Investigating impact of Vascular Endothelial Growth Factor Polymorphisms in Epithelial Ovarian Cancers: A Study in the Indian Population.研究血管内皮生长因子多态性在上皮性卵巢癌中的影响:一项印度人群的研究。
PLoS One. 2015 Jul 9;10(7):e0131190. doi: 10.1371/journal.pone.0131190. eCollection 2015.
4
Correlation of genetic polymorphism of vascular endothelial growth factor gene with susceptibility to lung cancer.血管内皮生长因子基因遗传多态性与肺癌易感性的相关性。
Cancer Gene Ther. 2015 Jun;22(6):312-6. doi: 10.1038/cgt.2015.24. Epub 2015 Jun 12.
5
Relationship of common vascular endothelial growth factor polymorphisms and haplotypes with the risk of cervical cancer in Tunisians.突尼斯人群中常见血管内皮生长因子多态性和单倍型与宫颈癌风险的关系。
Cytokine. 2015 Jul;74(1):108-12. doi: 10.1016/j.cyto.2014.11.009. Epub 2014 Dec 23.
6
Investigating the association of vascular endothelial growth factor polymorphisms with breast cancer: a Moroccan case-control study.血管内皮生长因子多态性与乳腺癌的关联研究:一项摩洛哥病例对照研究。
Med Oncol. 2014 Sep;31(9):193. doi: 10.1007/s12032-014-0193-3. Epub 2014 Aug 23.
7
Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.分化型甲状腺癌的预后与诊断时血清促甲状腺激素和甲状腺球蛋白抗体的状态有关。
Thyroid. 2014 Jan;24(1):35-42. doi: 10.1089/thy.2013.0062. Epub 2013 Sep 4.
8
Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas.血清促甲状腺激素水平升高与甲状腺微小乳头状癌风险之间缺乏关联。
Head Neck. 2014 Jan;36(1):43-6. doi: 10.1002/hed.23252. Epub 2013 Jun 1.
9
Thyrotropin values in patients with micropapillary thyroid cancer versus benign nodular disease.微乳头甲状腺癌患者与良性结节性疾病患者的促甲状腺激素值。
Endocr Pract. 2013 Jul-Aug;19(4):651-5. doi: 10.4158/EP12385.OR.
10
Correlation of E-cadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma.E-钙黏蛋白、VEGF、COX-2 表达与甲状腺乳头状癌预后参数的相关性。
Exp Mol Pathol. 2011 Jun;90(3):312-7. doi: 10.1016/j.yexmp.2011.01.008. Epub 2011 Feb 16.

血管内皮生长因子G+405C多态性可能会增加患乳头状甲状腺癌的风险。

Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.

作者信息

Bingül İlknur, Vural Pervin, Doğru-Abbasoğlu Semra, Çil Esra, Uysal Müjdat

机构信息

Istanbul Faculty of Medicine, Department of Biochemistry, Istanbul University, Istanbul, Turkey.

II. Internal Medicine Clinic, Department of Endocrinology, Şişli Etfal Education and Research Hospital, Istanbul, Turkey.

出版信息

J Clin Lab Anal. 2017 Nov;31(6). doi: 10.1002/jcla.22110. Epub 2016 Dec 7.

DOI:10.1002/jcla.22110
PMID:27925342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6817295/
Abstract

BACKGROUND

Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy. Vascular endothelial growth factor (VEGF) is a mediator implicated with cell proliferation, differentiation and migration, and monocyte/macrophage chemotaxis. In present study, we aimed to investigate the relationship between VEGF gene polymorphisms (G+405C, T-460C, and A-2578C) and PTC susceptibility.

METHODS

DNA was isolated from peripheral blood leukocytes of 127 patients with PTC and 203 healthy controls. Genotyping was performed by real-time PCR. Association of genotypes with susceptibility of PTC was analyzed with multivariate logistic regression adjusted for age, gender and smoking status.

RESULTS AND CONCLUSION

In G+405C polymorphism, the frequencies of C allele (related with increased VEGF production) and combined CG+CC genotype were found to be higher (3.5 and 5-fold, respectively) among patients with PTC than controls (P<.001). However, VEGF T-460C and A-2578C polymorphisms are not associated with PTC risk. There was no relationship between VEGF polymorphisms and clinical/laboratory parameters of PTC. Haplotype analysis demonstrated that there was a strong linkage disequilibrium (LD) between -460/-2578 (D'=.89, r =.79), weak LD between +405/-460 (D'=.422, r =.035), and +405/-2578 (D'=.43, r =.038) locuses. Additionally, the +405/-460/-2578 GTA haplotype was found to be protective, whereas CTA haplotype to be related with increased PTC risk. As a conclusion, we suggest that VEGF G+405C polymorphism is associated with increased risk of PTC.

摘要

背景

甲状腺乳头状癌(PTC)是最常见的内分泌恶性肿瘤。血管内皮生长因子(VEGF)是一种与细胞增殖、分化、迁移以及单核细胞/巨噬细胞趋化性有关的介质。在本研究中,我们旨在探讨VEGF基因多态性(G+405C、T-460C和A-2578C)与PTC易感性之间的关系。

方法

从127例PTC患者和203例健康对照者的外周血白细胞中提取DNA。通过实时PCR进行基因分型。采用多因素logistic回归分析调整年龄、性别和吸烟状态后基因型与PTC易感性的关联。

结果与结论

在G+405C多态性中,发现PTC患者中与VEGF产生增加相关的C等位基因频率以及CG+CC基因型频率分别比对照组高3.5倍和5倍(P<0.001)。然而,VEGF的T-460C和A-2578C多态性与PTC风险无关。VEGF多态性与PTC的临床/实验室参数之间没有关系。单倍型分析表明,-460/-2578位点之间存在强连锁不平衡(LD)(D'=0.89,r=0.79),+405/-460位点之间存在弱LD(D'=0.422,r=0.035),+405/-2578位点之间存在弱LD(D'=0.43,r=0.038)。此外,发现+405/-460/-2578 GTA单倍型具有保护作用,而CTA单倍型与PTC风险增加有关。总之,我们认为VEGF G+405C多态性与PTC风险增加有关。